These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3134380)
21. [Therapy of hyperlipidemia. Recommendations of the European Arteriosclerosis Society]. Med Monatsschr Pharm; 1988 Mar; 11(3):117-9. PubMed ID: 3287113 [No Abstract] [Full Text] [Related]
22. [Fibrates in the treatment of hyperlipidemia]. Kłosiewicz-Latoszek L; Szostak WB Wiad Lek; 1993 Nov; 46(21-22):872-6. PubMed ID: 7817584 [No Abstract] [Full Text] [Related]
23. Drugs for lipid disorders. Treat Guidel Med Lett; 2003 Aug; 1(12):77-82. PubMed ID: 15529095 [No Abstract] [Full Text] [Related]
24. A collective failure of medical practice? Faergeman O Eur Heart J; 2001 Apr; 22(7):526-8. PubMed ID: 11259137 [No Abstract] [Full Text] [Related]
28. NHF guidelines on the management of dyslipidaemia. Mann J; Agnew T N Z Med J; 1996 Sep; 109(1029):345. PubMed ID: 8862356 [No Abstract] [Full Text] [Related]
29. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering. Wilcock M Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882 [No Abstract] [Full Text] [Related]
30. Management of hyperlipidaemia: postscript. Sum CF; Tan CE; Chew LS Singapore Med J; 1995 Oct; 36(5):538. PubMed ID: 8882543 [No Abstract] [Full Text] [Related]
31. [Drugs in hyperlipidemia]. Stuyt PM Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435 [No Abstract] [Full Text] [Related]
32. Pharmacologic treatment of dyslipidemia. McCormick JJ; Deeg MA Am J Nurs; 2000 Feb; 100(2):55-60. PubMed ID: 10683645 [No Abstract] [Full Text] [Related]
33. Managing dyslipidaemia: current concepts. Schachter M Practitioner; 2002 Jul; 246(1636):496-9. PubMed ID: 12132267 [No Abstract] [Full Text] [Related]
34. [Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects]. Bielmann P; Annable L; Brun D; Moorjani S; Lupien PJ; Tétreault L Union Med Can; 1975 Jun; 104(6):930-4. PubMed ID: 1224412 [No Abstract] [Full Text] [Related]
35. Drug therapy. VI. Therapy of hyperlipidemias. Holcenberg JS; Hazzard WR Northwest Med; 1970 Jul; 69(7):503-5. PubMed ID: 5469352 [No Abstract] [Full Text] [Related]
36. [The possible means for the pharmacological correction of lipid metabolic disorders in atherosclerosis]. Piskun RP; Pentiuk AA; Serkova VK; Polesia TL; Savitskaia EA Eksp Klin Farmakol; 1997; 60(2):78-85. PubMed ID: 9206580 [TBL] [Abstract][Full Text] [Related]
37. Improving lipid goal attainment: is it enough? Gotto AM Circulation; 2009 Jul; 120(1):3-5. PubMed ID: 19546383 [No Abstract] [Full Text] [Related]